The overall goal of this project is to define the function of the protein tyrosine phosphatase SHP-1 in viral infections of the CNS. SHP-1 is expressed at especially high levels in mature oligodendrocytes and in the CNS white matter of mice. Mice genetically deficient in SHP- I (motheaten and viable motheaten mice) have a dramatically increased susceptibility to the attenuated BeAn strain of Theiler's murine encephalomyelitis virus (TMEV) following intracerebral inoculation. These mice display numerous virus-infected cells in spinal cords, extensive demyelination and spastic limb paralysis, and greatly increased virus replication. In vitro, motheaten mouse oligodendrocytes infected with TMEV show increased cytopathic effects and virus replication and do not respond normally to the antiviral activities of IFN-J3. Taken together, it is proposed that rapid onset of demyelination in motheaten mice represents a defect in the interferon system in oligodendrocytes. Proposed studies are focused on determining the role of SHP- 1 in the appropriate induction of antiviral state genes by analyzing altered responses in motheaten relative to normal littermate cells.
The specific aims are first to quantify replication and spread of TMEV in oligodendrocytes both in vitro and in the CNS of motheaten and normal littermate mice using standard virological techniques. Second, the altered expression and activity of antiviral state and pro-apoptotic genes in purified cultured oligodendrocytes from these mice will be determined using molecular approaches to detect protein and mRNA of these genes. Third, the mechanism by which SHP-l mediates interferon signaling in oligodendrocytes will be determined using techniques to analyze transcription factor activation. In this way, the role for SHP-l expression in oligodendrocytes in protecting against CNS virus infections will be characterized. It is proposed that SHP-1 plays an essential role in the mediating the actions of the interferons and virus-host interactions in the CNS.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS041593-03
Application #
6639768
Study Section
Special Emphasis Panel (ZRG1-BDCN-4 (01))
Program Officer
Utz, Ursula
Project Start
2001-04-15
Project End
2004-03-31
Budget Start
2003-04-01
Budget End
2004-03-31
Support Year
3
Fiscal Year
2003
Total Cost
$190,000
Indirect Cost
Name
Upstate Medical University
Department
Neurology
Type
Schools of Medicine
DUNS #
058889106
City
Syracuse
State
NY
Country
United States
Zip Code
13210
Christophi, George P; Caza, Tiffany; Curtiss, Christopher et al. (2014) Gene expression profiles in granuloma tissue reveal novel diagnostic markers in sarcoidosis. Exp Mol Pathol 96:393-9
Christophi, George P; Rong, Rong; Holtzapple, Philip G et al. (2012) Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 18:2342-56
Christophi, George P; Christophi, Jennifer A; Gruber, Ross C et al. (2011) Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-ýý 1a treated multiple sclerosis patients. J Neurol Sci 307:41-5
Christophi, George P; Hudson, Chad A; Panos, Michael et al. (2009) Modulation of macrophage infiltration and inflammatory activity by the phosphatase SHP-1 in virus-induced demyelinating disease. J Virol 83:522-39
Christophi, George P; Panos, Michael; Hudson, Chad A et al. (2009) Interferon-beta treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1. Clin Immunol 133:27-44
Christophi, George P; Massa, Paul T (2009) Central neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1. Viral Immunol 22:371-87
Christophi, George P; Panos, Michael; Hudson, Chad A et al. (2009) Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype. Lab Invest 89:742-59
Christophi, George P; Hudson, Chad A; Gruber, Ross C et al. (2008) SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients. Lab Invest 88:243-55
Hudson, Chad A; Christophi, George P; Gruber, Ross C et al. (2008) Induction of IL-33 expression and activity in central nervous system glia. J Leukoc Biol 84:631-43
Christophi, George P; Hudson, Chad A; Gruber, Ross et al. (2008) Promoter-specific induction of the phosphatase SHP-1 by viral infection and cytokines in CNS glia. J Neurochem 105:2511-23

Showing the most recent 10 out of 14 publications